viral mimicry in antitumor
therapy of BC may be the simultaneous suppression of specific
Перспективы эпигенетической терапии плоскоклеточного рака головы и шеиProspects of epigenetic
therapy of head and neck squamous cell carcinoma
Fedorova, Yu Yu,
Sagitova, A.V.,
Mingazheva, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Khusnutdinova, E.K.,
Darvish, M.,
Prokofyeva, D.S. (2024) researched – 89.91%, despite a good response to primary
therapy, had a relapse of the disease after 7 years
RNAs. Therefore, targeted
therapy aimed at specific non-coding RNAs to restore normal expression of NF1 gene can